Specific and Slow Inhibition of the Kir2.1 K+ Channel by Gambogic Acid*
AUTOR(ES)
Zaks-Makhina, Elena
FONTE
American Society for Biochemistry and Molecular Biology
RESUMO
Although Kir2.1 channels are important in the heart and other excitable cells, there are virtually no specific drugs for this K+ channel. In search of Kir2.1 modulators, we screened a library of 720 naturally occurring compounds using a yeast strain in which mammalian Kir2.1 enables growth at low [K+]. One of the identified compounds, gambogic acid (GA), potently (EC50 ≤ 100 nm) inhibited Kir2.1 channels in mammalian cells when applied chronically for 3 h. This potent and slow inhibition was not seen with Kv2.1, HERG or Kir1.1 channels. However, acutely applied GA acted as a weak (EC50 = ∼10 μm) non-selective K+ channel blocker. Intracellular delivery of GA via a patch pipette did not potentiate the acute effect of GA on Kir2.1, showing that slow uptake is not responsible for the delayed, potent effect. Immunoblots showed that total Kir2.1 protein expression was not altered by GA. Similarly, immunostaining of intact cells expressing Kir2.1 with an extracellular epitope tag demonstrated that GA does not affect Kir2.1 surface expression. However, the 3-h treatment with GA caused redistribution of Kir2.1 and Kv2.1 from the Triton X-100-insoluble to the Triton X-100-soluble membrane fraction. Thus, GA changes the K+ channel membrane microenvironment resulting in potent, specific, and slow acting inhibition of Kir2.1 channels.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2708840Documentos Relacionados
- Shear stress regulates the endothelial Kir2.1 ion channel
- Characterization of the chicken inward rectifier K+ channel IRK1/Kir2.1 gene
- The role of a single aspartate residue in ionic selectivity and block of a murine inward rectifier K+ channel Kir2.1.
- Flexibility of the Kir6.2 inward rectifier K+ channel pore
- Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility